Insulet Corp. (PODD)
131.69
+0.90
(+0.69%)
USD |
NASDAQ |
Oct 02, 16:00
131.64
-0.05
(-0.04%)
After-Hours: 20:00
Insulet Profit Margin (Quarterly) : 11.85% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.85% |
| March 31, 2026 | 11.96% |
| December 31, 2025 | 12.96% |
| September 30, 2025 | 12.40% |
| June 30, 2025 | 3.47% |
| March 31, 2025 | 6.22% |
| December 31, 2024 | 16.85% |
| September 30, 2024 | 14.25% |
| June 30, 2024 | 38.61% |
| March 31, 2024 | 11.66% |
| December 31, 2023 | 20.26% |
| September 30, 2023 | 11.99% |
| June 30, 2023 | 6.89% |
| March 31, 2023 | 6.65% |
| December 31, 2022 | 4.60% |
| September 30, 2022 | -1.53% |
| June 30, 2022 | -11.69% |
| March 31, 2022 | 9.41% |
| December 31, 2021 | 9.49% |
| September 30, 2021 | 4.57% |
| June 30, 2021 | -9.50% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | -6.95% |
| September 30, 2020 | 4.96% |
| June 30, 2020 | 6.36% |
| Date | Value |
|---|---|
| March 31, 2020 | -1.06% |
| December 31, 2019 | 2.39% |
| September 30, 2019 | 0.44% |
| June 30, 2019 | 0.79% |
| March 31, 2019 | 2.74% |
| December 31, 2018 | 6.00% |
| September 30, 2018 | 1.10% |
| June 30, 2018 | -1.36% |
| March 31, 2018 | -5.32% |
| December 31, 2017 | -5.26% |
| September 30, 2017 | -1.83% |
| June 30, 2017 | -7.08% |
| March 31, 2017 | -9.81% |
| December 31, 2016 | -8.84% |
| September 30, 2016 | -3.18% |
| June 30, 2016 | -4.98% |
| March 31, 2016 | -13.16% |
| December 31, 2015 | -27.29% |
| September 30, 2015 | -25.19% |
| June 30, 2015 | -20.42% |
| March 31, 2015 | -19.33% |
| December 31, 2014 | -7.44% |
| September 30, 2014 | -14.46% |
| June 30, 2014 | -40.42% |
| March 31, 2014 | -8.88% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| DexCom, Inc. | 19.04% |
| Abbott Laboratories | 7.37% |
| Boston Scientific Corp. | 16.63% |
| PROCEPT BioRobotics Corp. | -28.42% |
| Globus Medical, Inc. | 19.20% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 26.48% |
| Return on Assets | 11.85% |
| Return on Invested Capital | 15.09% |
| Gross Profit Margin (Quarterly) | 72.56% |
| Operating Margin (Quarterly) | 16.15% |
| Return on Net Operating Assets | 19.27% |